Listed

Nephros Inc: Form 10-Q for the period ended Jun 30, 2015

Filed with the SEC on Aug 10, 2015 and accepted by EDGAR at Aug 10, 2015, 16:17 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-04-01 to 2015-06-30$567.0kus-gaap:SalesRevenueNet
Revenue6 months2015-01-01 to 2015-06-30$1.1mus-gaap:SalesRevenueNet
Cost of revenue3 months2015-04-01 to 2015-06-30$209.0kus-gaap:CostOfGoodsSold
Cost of revenue6 months2015-01-01 to 2015-06-30$471.0kus-gaap:CostOfGoodsSold
Gross profit3 months2015-04-01 to 2015-06-30$358.0kus-gaap:GrossProfit
Gross profit6 months2015-01-01 to 2015-06-30$641.0kus-gaap:GrossProfit
Selling, general and administrative3 months2015-04-01 to 2015-06-30$735.0kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2015-01-01 to 2015-06-30$1.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2015-04-01 to 2015-06-30−$594.0kus-gaap:OperatingIncomeLoss
Operating income6 months2015-01-01 to 2015-06-30−$1.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2015-04-01 to 2015-06-30$9.0kus-gaap:InterestExpense
Interest expense6 months2015-01-01 to 2015-06-30$21.0kus-gaap:InterestExpense
Net income3 months2015-04-01 to 2015-06-30−$1.8mus-gaap:NetIncomeLoss
Net income6 months2015-01-01 to 2015-06-30−$1.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-04-01 to 2015-06-30−$0.06us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2015-01-01 to 2015-06-30−$0.05us-gaap:EarningsPerShareBasicAndDiluted
Basic EPS3 months2015-04-01 to 2015-06-30−$0.06us-gaap:EarningsPerShareBasic
Basic EPS6 months2015-01-01 to 2015-06-30−$0.05us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-04-01 to 2015-06-3031,190,714 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2015-01-01 to 2015-06-3030,727,840 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2015-01-01 to 2015-06-30−$1.5mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2015-06-30$1.0mus-gaap:Cash
Current assetsAt period end2015-06-30$1.8mus-gaap:AssetsCurrent
Total assetsAt period end2015-06-30$3.4mus-gaap:Assets
Current liabilitiesAt period end2015-06-30$1.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-06-30$9.3mus-gaap:Liabilities
Shareholders' equityAt period end2015-06-30−$5.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-15-047743. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.